Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.30 |
| ▸ | CA2 | P00918 | 4/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL9838754 | 1.00 | TSHR (0.33) | TSHRALDH1A1CA1CA2CA5A | |
| Acetonitrile SCHEMBL19376785 | 1.00 | TSHR (0.33) | TSHRALDH1A1CA1CA2CA5A | |
| Acetonitrile SCHEMBL288686 | 1.00 | — | — | |
| Acetonitrile SCHEMBL9935942 | 1.00 | TSHR (0.33) | TSHRALDH1A1CA1CA2CA5A | |
| Acetonitrile SCHEMBL490215 | 1.00 | — | — | |
| Acetonitrile SCHEMBL25284595 | 1.00 | TSHR (0.33) | TSHRALDH1A1CA1CA2CA5A | |
| Acetonitrile SCHEMBL27867164 | 1.00 | — | — | |
| Acetonitrile SCHEMBL167513 | 1.00 | — | — | |
| Acetonitrile SCHEMBL1571600 | 1.00 | — | — | |
| Acetonitrile SCHEMBL2186630 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9409940-B2 | Preparation process of erythromycin thiocyanate | HEC PHARM CO., LTD. (CN) | 2016-08-09 | — | — | US | disclosed |
| US-20140228555-A1 | PREPARATION PROCESS OF ERYTHROMYCIN THIOCYANATE | HEC PHARM CO., LTD (CN) | 2014-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140228555-A1 | PREPARATION PROCESS OF ERYTHROMYCIN THIOCYANATE | TPMT, TST, SRP9 | TSHR 1007/4885ALDH1A1 4158/4885CA1 4584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.